or
forgot password

    • cancer clinical trials in utica, NY

    • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Faxton Regional Cancer Center
    Utica, New York 13502
    Breast Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Faxton Regional Cancer Center
    Utica, New York 13502
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Faxton-Saint Luke's Healthcare
    Utica, New York 13502
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Faxton Regional Cancer Center
    Utica, New York 13502
    Lung Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Faxton Regional Cancer Center
    Utica, New York 13502
    Breast Cancer, Osteoporosis
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Faxton Regional Cancer Center
    Utica, New York 13502
    Pancreatic Cancer
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Faxton Regional Cancer Center
    Utica, New York 13502
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    Assessment and Tracking of Long-term Alefacept Safety
    Martin Morell, MD
    Utica, New York 13502
    Psoriasis
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Faxton Regional Cancer Center
    Utica, New York 13502
    Breast Cancer